The UK Competition and Markets Authority has opened a Phase I review into McCormick (MKC)'s planned $44.8b purchase of Unilever's food assets, prompting investors to reassess the stock's risk profile.
McCormick and Unilever plan to sell the Colman's mustard brand to ease competition concerns, while the current deal terms would leave Unilever shareholders owning most of the combined food business.
For context, McCormick shares trade at US$50.06 after a 7.19% decline in the 30-day share price return that follows a 7.33% gain over 90 days. The 1-year total shareholder return is down 22.65%, suggesting longer term momentum has faded even as this acquisition news resets expectations around future risk and integration execution.
Spot regulatory pressure around McCormick and compare it with other consumer-focused opportunities by scanning the hand-picked 33 high quality undervalued stocks that combine quality fundamentals with discounted prices.McCormick still looks like a high quality spices and condiments powerhouse, yet the share price slide and regulatory overhang raise a blunt question: Is this now a solid business at a fair tag, or still too rich?
McCormick's most followed valuation narrative pegs fair value at $61.23, which sits well above the latest $50.06 close and frames the stock as discounted despite regulatory questions around the Unilever Foods deal.
Robust supply chain digitalization and continuous cost-reduction programs (CCI), combined with McCormick's ability to locally manufacture most of its products and mitigate tariff/commodity cost headwinds, are expected to drive operating margin expansion and limit downside risks to earnings.
See why 24 investors see McCormick as 18% undervalued.
The fair value estimate uses a 7.11% discount rate and incorporates analyst assumptions that revenue growth runs near 7.1% annually, while profit margins compress from roughly 23.1% to about 8.2% over the next few years. That mix of slower earnings power and ongoing top line expansion helps explain why the narrative still lands on an 18% discount, even though forecasts point to earnings declining on average 24.8% a year across the next three years.
Result: Fair Value of $61.23 (UNDERVALUED)
Still, this 18% discount thesis could unravel if raw material and tariff costs bite harder than expected, or if private label competition pressures McCormick’s pricing power.
Find out about the key risks to this McCormick narrative.
The mix of regulatory questions and valuation optimism around McCormick is already splitting opinion, so move quickly and test the numbers yourself against both sides of the story with 5 key rewards and 2 important warning signs.
Do not stop at McCormick. Use the Simply Wall St screener to uncover fresh opportunities that match your goals before everyone else is talking about them.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com